178 related articles for article (PubMed ID: 32572587)
1. Cytoplasmic VDR expression as an independent risk factor for ovarian cancer.
Czogalla B; Deuster E; Liao Y; Mayr D; Schmoeckel E; Sattler C; Kolben T; Hester A; Fürst S; Burges A; Mahner S; Jeschke U; Trillsch F
Histochem Cell Biol; 2020 Oct; 154(4):421-429. PubMed ID: 32572587
[TBL] [Abstract][Full Text] [Related]
2. Nuclear Enolase-1/ MBP-1 expression and its association with the Wnt signaling in epithelial ovarian cancer.
Czogalla B; Partenheimer A; Badmann S; Schmoeckel E; Mayr D; Kolben T; Beyer S; Hester A; Burges A; Mahner S; Jeschke U; Trillsch F
Transl Oncol; 2021 Jan; 14(1):100910. PubMed ID: 33069100
[TBL] [Abstract][Full Text] [Related]
3. Analysis of vitamin D receptor expression and clinical correlations in patients with ovarian cancer.
Silvagno F; Poma CB; Realmuto C; Ravarino N; Ramella A; Santoro N; D'Amelio P; Fuso L; Pescarmona G; Zola P
Gynecol Oncol; 2010 Oct; 119(1):121-4. PubMed ID: 20599260
[TBL] [Abstract][Full Text] [Related]
4. Expression of Vitamin D Receptor (VDR) Positively Correlates with Survival of Urothelial Bladder Cancer Patients.
Jóźwicki W; Brożyna AA; Siekiera J; Slominski AT
Int J Mol Sci; 2015 Oct; 16(10):24369-86. PubMed ID: 26501255
[TBL] [Abstract][Full Text] [Related]
5. Multivariate analysis by Cox proportional hazard model on prognosis of patient with epithelial ovarian cancer.
Wang M; He Y; Shi L; Shi C
Eur J Gynaecol Oncol; 2011; 32(2):171-7. PubMed ID: 21614907
[TBL] [Abstract][Full Text] [Related]
6. Displacement of Vitamin D Receptor Is Related to Lower Histological Grade of Endometrioid Carcinoma.
An HJ; Song DH
Anticancer Res; 2019 Aug; 39(8):4143-4147. PubMed ID: 31366499
[TBL] [Abstract][Full Text] [Related]
7. Cytoplasmic versus nuclear THR alpha expression determines survival of ovarian cancer patients.
Ditsch N; Heublein S; Jeschke U; Sattler C; Kuhn C; Hester A; Czogalla B; Trillsch F; Mahner S; Engel J; Mayr D; Schmoeckel E
J Cancer Res Clin Oncol; 2020 Aug; 146(8):1923-1932. PubMed ID: 32533406
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical Expression of Vitamin D Receptor (VDR) in Urinary Bladder Squamous Cell Carcinoma.
Sharaf RM; Eldin-Shibel PE; Abd-El-Moeze NA
Turk Patoloji Derg; 2024; 1(1):109-116. PubMed ID: 38265102
[TBL] [Abstract][Full Text] [Related]
9. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
[TBL] [Abstract][Full Text] [Related]
10. Alterations in vitamin D signaling pathway in gastric cancer progression: a study of vitamin D receptor expression in human normal, premalignant, and malignant gastric tissue.
Wen Y; Da M; Zhang Y; Peng L; Yao J; Duan Y
Int J Clin Exp Pathol; 2015; 8(10):13176-84. PubMed ID: 26722516
[TBL] [Abstract][Full Text] [Related]
11. [Expression and significance of PD-1 and PD-L1 in the specimens of epithelial ovarian cancer].
Ju C; Gao JC; Zhang PX; Zhang KN; Yang S; Kang TJ; Zhao HZ; Qi WJ; Zhang QP; Kong FD; Guan HW; Shi H
Zhonghua Fu Chan Ke Za Zhi; 2020 Aug; 55(8):529-534. PubMed ID: 32854477
[No Abstract] [Full Text] [Related]
12. Vitamin D-Binding Protein Enhances Epithelial Ovarian Cancer Progression by Regulating the Insulin-like Growth Factor-1/Akt Pathway and Vitamin D Receptor Transcription.
Huang YF; Wu YH; Cheng WF; Peng SL; Shen WL; Chou CY
Clin Cancer Res; 2018 Jul; 24(13):3217-3228. PubMed ID: 29476020
[No Abstract] [Full Text] [Related]
13. Predicted 25(OH)D score and colorectal cancer risk according to vitamin D receptor expression.
Jung S; Qian ZR; Yamauchi M; Bertrand KA; Fitzgerald KC; Inamura K; Kim SA; Mima K; Sukawa Y; Zhang X; Wang M; Smith-Warner SA; Wu K; Fuchs CS; Chan AT; Giovannucci EL; Ng K; Cho E; Ogino S; Nishihara R
Cancer Epidemiol Biomarkers Prev; 2014 Aug; 23(8):1628-37. PubMed ID: 24920642
[TBL] [Abstract][Full Text] [Related]
14. Correlation of the Aryl Hydrocarbon Receptor with FSHR in Ovarian Cancer Patients.
Deuster E; Mayr D; Hester A; Kolben T; Zeder-Göß C; Burges A; Mahner S; Jeschke U; Trillsch F; Czogalla B
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31212758
[TBL] [Abstract][Full Text] [Related]
15. RAN nucleo-cytoplasmic transport and mitotic spindle assembly partners XPO7 and TPX2 are new prognostic biomarkers in serous epithelial ovarian cancer.
Cáceres-Gorriti KY; Carmona E; Barrès V; Rahimi K; Létourneau IJ; Tonin PN; Provencher D; Mes-Masson AM
PLoS One; 2014; 9(3):e91000. PubMed ID: 24625450
[TBL] [Abstract][Full Text] [Related]
16. Expression level of Wilms tumor 1 (WT1) protein has limited prognostic value in epithelial ovarian cancer: from the Danish "MALOVA" ovarian cancer study.
Høgdall EV; Christensen L; Kjaer SK; Blaakaer J; Christensen IJ; Gayther S; Jacobs IJ; Høgdall CK
Gynecol Oncol; 2007 Aug; 106(2):318-24. PubMed ID: 17540436
[TBL] [Abstract][Full Text] [Related]
17. Nuclear vitamin D receptor expression is associated with improved survival in non-small cell lung cancer.
Srinivasan M; Parwani AV; Hershberger PA; Lenzner DE; Weissfeld JL
J Steroid Biochem Mol Biol; 2011 Jan; 123(1-2):30-6. PubMed ID: 20955794
[TBL] [Abstract][Full Text] [Related]
18. Suppression of epithelial ovarian cancer invasion into the omentum by 1α,25-dihydroxyvitamin D3 and its receptor.
Lungchukiet P; Sun Y; Kasiappan R; Quarni W; Nicosia SV; Zhang X; Bai W
J Steroid Biochem Mol Biol; 2015 Apr; 148():138-47. PubMed ID: 25448740
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical expression of vitamin D receptor in melanocytic naevi and cutaneous melanoma: a case-control study.
Del Puerto C; Navarrete-Dechent C; Molgó M; Camargo CA; Borzutzky A; González S
Br J Dermatol; 2018 Jul; 179(1):95-100. PubMed ID: 29106699
[TBL] [Abstract][Full Text] [Related]
20. Deregulation of microcephalin and ASPM expression are correlated with epithelial ovarian cancer progression.
Alsiary R; Brüning-Richardson A; Bond J; Morrison EE; Wilkinson N; Bell SM
PLoS One; 2014; 9(5):e97059. PubMed ID: 24830737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
